Washington Patent of the Month – July 2024
Dopl Technologies, Inc., a data and AI company, has patented a new remote robotic medical platform designed to enhance surgical precision and efficiency. This groundbreaking invention integrates advanced technologies to facilitate real-time communication and control during surgeries conducted at remote sites.
At the core of Dopl’s platform is a sophisticated state manager that synchronizes diverse sensory data streams in near-real-time. These streams, generated by medical provisioning equipment at the patient site, include vital information such as positional data, environmental metrics, and procedural feedback. By aggregating and processing this data into a cohesive virtual representation of the operative field, the platform ensures that surgeons receive accurate and actionable insights without physical proximity to the patient.
Key to its functionality is a cloud-based infrastructure that enables scalable deployment and seamless integration with existing medical systems. The platform leverages artificial intelligence to autonomously manage surgical tasks, optimizing workflow efficiency and reducing reliance on manual intervention. This capability not only improves surgical outcomes but also mitigates risks associated with human error.
Dopl’s platform includes a data broker component that tailors information subsets to specific procedural requirements, enhancing operational flexibility. Whether visualizing intricate anatomical details or adjusting robotic instruments remotely, the system adapts dynamically to the surgeon’s needs in real-time.
Beyond its technical prowess, Dopl’s invention addresses significant challenges in modern healthcare, including cost barriers and radiation exposure risks associated with conventional surgical techniques. By facilitating remote surgeries with minimal latency and maximal precision, the platform expands access to specialized care while safeguarding the well-being of medical personnel.
Dopl Technologies’ platform represents a paradigm shift in surgical robotics, offering a comprehensive solution to the complexities of remote medical procedures. As healthcare continues to embrace technological innovation, Dopl stands at the forefront, paving the way for safer, more efficient surgical practices worldwide.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
